SCHEMBL20090087

SCHEMBL20090087

O=P(c1ccc2ccccc2c1)(c1ccc2ccccc2c1)c1ccc2cc(-c3ccc4c5c6ccccc6ccc5c5nc6ccccc6n5c4c3)ccc2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCL2 P10415 1/20 0.40
HPGD P15428 5/20 0.40
ALDH1A1 P00352 4/20 0.40
KDM4E B2RXH2 4/20 0.40
KMT2A Q03164 5/20 0.40
MAPT P10636 4/20 0.40
MEN1 O00255 3/20 0.40
CYP1A2 P05177 2/20 0.40
CAMKK1 Q8N5S9 2/20 0.40
CAMKK2 Q96RR4 2/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
CASP1 P29466 1/20 0.40
CYP2C19 P33261 1/20 0.40
CASP7 P55210 1/20 0.40
NPC1 O15118 1/20 0.39
CYP3A4 P08684 1/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
POLB P06746 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20090077 0.96 HPGD (0.41) BCL2HPGDALDH1A1KDM4EKMT2A
SCHEMBL20090091 0.93 NPC1 (0.38) BCL2HPGDALDH1A1KDM4EKMT2A
SCHEMBL20090102 0.93 BCL2 (0.36) BCL2HPGDALDH1A1KDM4EKMT2A
SCHEMBL19960328 0.92 AHR (0.36) BCL2HPGDALDH1A1KDM4EKMT2A
SCHEMBL14643513 0.92 HPGD (0.44) BCL2HPGDALDH1A1KDM4EKMT2A
SCHEMBL20090130 0.92 HPGD (0.44) BCL2HPGDALDH1A1KDM4EKMT2A
SCHEMBL14643738 0.91 HPGD (0.47) BCL2HPGDALDH1A1KDM4EKMT2A
SCHEMBL20090248 0.91 AHR (0.36) BCL2HPGDALDH1A1KDM4EKMT2A
SCHEMBL19960324 0.91 AHR (0.36) BCL2HPGDALDH1A1KDM4EKMT2A
SCHEMBL22456900 0.90 BCL2 (0.39) BCL2HPGDALDH1A1KDM4EKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10355225-B2 Heterocyclic compound and organic light emitting element comprising same LG CHEM, LTD. (KR) 2019-07-16 US disclosed
US-20180114923-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-04-26 US disclosed
US-20180114923-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-04-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180114923-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME CRY1, CRY2, PER2 BCL2 2578/4885HPGD 2982/4885ALDH1A1 750/4885
US-10355225-B2 Heterocyclic compound and organic light emitting element comprising same CRY1, CRY2, PER2 BCL2 2578/4885HPGD 2982/4885ALDH1A1 750/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.